Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Share-based Compensation (2010 - 2026)

Exelixis (EXEL) posted quarterly Share-based Compensation of $34.2 million for Q2 2026, up 52.03% year-over-year from $22.5 million in Q2 2025, and up 70.33% quarter-over-quarter from $20.1 million in Q1 2026.

Analysis

Exelixis (EXEL) Share-based Compensation (2010 - 2026) Analysis & Trends

Exelixis' Share-based Compensation history runs 17 years deep, the most recent figure standing at $34.2 million for Q2 2026.

  • In Q2 2026, Share-based Compensation rose 52.03% year-over-year to $34.2 million; the TTM figure through Apr 2026 stood at $124.7 million (up 566.26% YoY), while the FY2026 annual figure was $113.0 million, up 637.82% from the prior year.
  • Share-based Compensation for Q2 2026 stood at $34.2 million, up from $20.1 million in the prior quarter.
  • The five-year high for Share-based Compensation was $91.5 million in Q4 2022, with the low at -$52.2 million in Q1 2025.
  • The 5-year median for Share-based Compensation is $19.1 million (2024), against an average of $16.9 million.
  • The sharpest annual moves came in 2022 and 2025: Share-based Compensation tumbled 1468.43% in 2022, then jumped 4282.35% in 2025.
  • Exelixis' Share-based Compensation stood at $91.5 million in 2022, then slumped by 107.12% to -$6.5 million in 2023, then soared by 828.94% to $47.5 million in 2024, then plunged by 34.95% to $30.9 million in 2025, then advanced by 10.83% to $34.2 million in 2026.
  • Business Quant data shows EXEL's Share-based Compensation at $34.2 million in Q2 2026, $20.1 million in Q1 2026, and $30.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 36.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 36.34 Mn
Apr 3, 2026 34.23 Mn
Jan 2, 2026 20.10 Mn
Oct 3, 2025 29.87 Mn
Jul 4, 2025 37.09 Mn
Apr 4, 2025 25.93 Mn
Jan 3, 2025 26.35 Mn
Sep 27, 2024 23.02 Mn
Jun 28, 2024 25.35 Mn
Mar 29, 2024 19.11 Mn
Dec 29, 2023 24.31 Mn
Sep 29, 2023 40.48 Mn
Jun 30, 2023 24.90 Mn
Mar 31, 2023 16.66 Mn
Dec 30, 2022 33.98 Mn
Sep 30, 2022 1.60 Mn
Jul 1, 2022 100.60 Mn
Apr 1, 2022 19.76 Mn
Dec 31, 2021 23.17 Mn
Oct 1, 2021 33.97 Mn